866-997-4948(US-Canada Toll Free)

2017-2022 Global and Japan Immune system drugs Market Analysis Report

Published By :

Jp Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

The global Immune system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Immune system drugs market's development status and future trend in the global and Japan. It splits Immune system drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
Asahi Kasei Pharma Corporation
Aspen Japan K.K.
AYUMI Pharmaceutical Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Nichi-iko Pharmaceutical Co.,Ltd
NIPPON KAYAKU
NIPRO CORPORATION
Novartis Pharma K.K.
Pfizer Pharmaceuticals Inc.
POLA PHARMA INC.
Sawai Pharmaceutical Co.,Ltd.
Teva Takeda Pharma Ltd.

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Immune system drugs market is primarily split into
Immune system drugs Market, by Immunosuppressive drugs
Azathioprine
Tripterygium Glycosides
Cyclosporine
Sandimmune
Ciclosporin
Cyclosporine
Neoral
Tacrolimus
Rapamycin
Mycophenolate
Everolimus
Diacerein
Mizoribine
Gusperimus
Etanercept
Muromonab-CD3
Cyclophosphamide
Fingolimod
Leflunomide
Imiquimod
Chloroquinum
Methotrexate
Immune system drugs Market, by Immunoregulants
Inosine pranobex
Melotonin
Killer helper factor,KHF
Thymopentin
Interleukin
-globulin
Interferon
Ubenimex
Pidotimod
Thymopentin
Key Applications
Internal Medicine
Department of surgery
Infections Department
Hospital


Table of Contents



2017-2022 Global and Japan Immune system drugs Market Analysis Report

1 Immune system drugs Overview

1.1 Product Overview and Scope of Immune system drugs

1.2 Global and Japan Immune system drugs Market by Applications/End Users

1.2.1 Japan Immune system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.1.1 Japan Immune system drugs Sales () and Market Share by Applications (2012-2017)

1.2.1.2 Japan Immune system drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.1.3 Market Drivers and Opportunities

1.2.2 Japan Immune system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.3 Global Immune system drugs Sales by Application (2012-2017)

1.2.3.1 Global Immune system drugs Sales () and Market Share by Applications (2012-2017)

1.2.3.2 Global Immune system drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.3.3 Market Drivers and Opportunities

1.2.4 Global Immune system drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.5 Internal Medicine

1.2.6 Department of surgery

1.2.7 Infections Department

1.2.8 Hospital

1.3 Global and Japan Market Size (Sales and Revenue) of Immune system drugs (2012-2017)

1.3.1 Japan Market Size (Sales and Revenue) of Immune system drugs (2012-2017)

1.3.1.1 Japan Immune system drugs Sales () and Growth Rate (%) (2012-2017)

1.3.1.2 Japan Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.3.2 Global Market Size (Sales and Revenue) of Immune system drugs (2012-2017)

1.3.2.1 Global Immune system drugs Sales () and Growth Rate (%) (2012-2017)

1.3.2.2 Global Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.4 Global and Japan Classification of Immune system drugs by Immunosuppressive drugs

1.4.1 Japan Immune system drugs Sales () and Market Share by Immunosuppressive drugs (2012-2017)

1.4.2 Global Immune system drugs Sales () and Market Share by Immunosuppressive drugs (2012-2017)

1.4.3 Japan Immune system drugs Revenue (Million USD) and Market Share by Immunosuppressive drugs (2012-2017)

1.4.4 Global Immune system drugs Revenue (Million USD) and Market Share by Immunosuppressive drugs (2012-2017)

1.4.5 Japan Immune system drugs Price () by Immunosuppressive drugs (2012-2017)

1.4.6 Global Immune system drugs Price () by Immunosuppressive drugs (2012-2017)

1.4.7 Japan Immune system drugs Sales Growth Rate (%) by Immunosuppressive drugs (2012-2017)

1.4.8 Global Immune system drugs Sales Growth Rate (%) by Immunosuppressive drugs (2012-2017)

1.4.9 Azathioprine

1.4.10 Tripterygium Glycosides

1.4.11 Cyclosporine

1.4.12 Sandimmune

1.4.13 Ciclosporin

Cyclosporine

Neoral

Tacrolimus

Rapamycin

Mycophenolate

Everolimus

Diacerein

Mizoribine

Gusperimus

Etanercept

Muromonab-CD3

Cyclophosphamide

Fingolimod

Leflunomide

Imiquimod

Chloroquinum

Methotrexate

1.5 Global and Japan Classification of Immune system drugs by Immunoregulants

1.5.1 Japan Immune system drugs Sales () and Market Share by Immunoregulants (2012-2017)

1.5.2 Global Immune system drugs Sales () and Market Share by Immunoregulants (2012-2017)

1.5.3 Japan Immune system drugs Revenue (Million USD) and Market Share by Immunoregulants (2012-2017)

1.5.4 Global Immune system drugs Revenue (Million USD) and Market Share by Immunoregulants (2012-2017)

1.5.5 Japan Immune system drugs Price () by Immunoregulants (2012-2017)

1.5.6 Global Immune system drugs Price () by Immunoregulants (2012-2017)

1.5.7 Japan Immune system drugs Sales Growth Rate (%) by Immunoregulants (2012-2017)

1.5.8 Global Immune system drugs Sales Growth Rate (%) by Immunoregulants (2012-2017)

1.5.9 Inosine pranobex

1.5.10 Melotonin

1.5.11 Killer helper factor,KHF

1.5.12 Thymopentin

1.5.13 Interleukin

-globulin

Interferon

Ubenimex

Pidotimod

Thymopentin



2 Global and Japan Immune system drugs Market Competition by Players/Manufacturers

2.1 Japan Immune system drugs Market Competition by Players/Manufacturers

2.1.1 Japan Immune system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.1.2 Japan Immune system drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.1.3 Japan Immune system drugs Average Price () by Players/Manufacturers (2012-2017)

2.1.4 Japan Immune system drugs Market Competitive Situation and Trends

2.1.4.1 Japan Immune system drugs Market Concentration Rate

2.1.4.2 Japan Immune system drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market

2.1.5 Japan Players/Manufacturers Immune system drugs Manufacturing Base Distribution, Sales Area, Product Types

2.2 Global Immune system drugs Market Competition by Players/Manufacturers

2.2.1 Global Immune system drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2.2 Global Immune system drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.2.3 Global Immune system drugs Average Price () by Players/Manufacturers (2012-2017)

2.2.4 Global Immune system drugs Market Competitive Situation and Trends

2.2.4.1 Global Immune system drugs Market Concentration Rate

2.2.4.2 Global Immune system drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.2.4.3 Mergers & Acquisitions, Expansion in Global Market

2.2.5 Global Players/Manufacturers Immune system drugs Manufacturing Base Distribution, Sales Area, Product Types



3 Global and Japan Immune system drugs Sales and Revenue by Regions (2012-2017)

3.1 Asia Pacific Immune system drugs Sales and Revenue by Regions (2012-2017)

3.1.1 Japan Immune system drugs Sales and Revenue (2012-2017)

3.1.1.1 Japan Immune system drugs Sales () and Market Share (2012-2017)

3.1.1.2 Japan Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.1.3 Japan Immune system drugs Price ()(2012-2017)

3.1.2 China Immune system drugs Sales and Revenue (2012-2017)

3.1.2.1 China Immune system drugs Sales () and Market Share (2012-2017)

3.1.2.2 China Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.2.3 China Immune system drugs Price ()(2012-2017)

3.1.3 Korea Immune system drugs Sales and Revenue (2012-2017)

3.1.3.1 Korea Immune system drugs Sales () and Market Share (2012-2017)

3.1.3.2 Korea Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.3.3 Korea Immune system drugs Price ()(2012-2017)

3.1.4 India Immune system drugs Sales and Revenue (2012-2017)

3.1.4.1 India Immune system drugs Sales () and Market Share (2012-2017)

3.1.4.2 India Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.4.3 India Immune system drugs Price ()(2012-2017)

3.1.5 Others Immune system drugs Sales and Revenue (2012-2017)

3.1.5.1 Others Immune system drugs Sales () and Market Share (2012-2017)

3.1.5.2 Others Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.5.3 Others Immune system drugs Price ()(2012-2017)

3.2 Europe Immune system drugs Sales and Revenue by Regions (2012-2017)

3.2.1 France Immune system drugs Sales and Revenue (2012-2017)

3.2.1.1 France Immune system drugs Sales () and Market Share (2012-2017)

3.2.1.2 France Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.1.3 France Immune system drugs Price ()(2012-2017)

3.2.2 Germany Immune system drugs Sales and Revenue (2012-2017)

3.2.2.1 Germany Immune system drugs Sales () and Market Share (2012-2017)

3.2.2.2 Germany Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.2.3 Germany Immune system drugs Price ()(2012-2017)

3.2.3 United Kingdom Immune system drugs Sales and Revenue (2012-2017)

3.2.3.1 United Kingdom Immune system drugs Sales () and Market Share (2012-2017)

3.2.3.2 United Kingdom Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.3.3 United Kingdom Immune system drugs Price ()(2012-2017)

3.2.4 Italy Immune system drugs Sales and Revenue (2012-2017)

3.2.4.1 Italy Immune system drugs Sales () and Market Share (2012-2017)

3.2.4.2 Italy Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.4.3 Italy Immune system drugs Price ()(2012-2017)

3.2.5 Russia Immune system drugs Sales and Revenue (2012-2017)

3.2.5.1 Russia Immune system drugs Sales () and Market Share (2012-2017)

3.2.5.2 Russia Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.5.3 Russia Immune system drugs Price ()(2012-2017)

3.2.6 Others Immune system drugs Sales and Revenue (2012-2017)

3.2.6.1 Others Immune system drugs Sales () and Market Share (2012-2017)

3.2.6.2 Others Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.6.3 Others Immune system drugs Price ()(2012-2017)

3.3 North America Immune system drugs Sales and Revenue by Regions (2012-2017)

3.3.1 United States Immune system drugs Sales and Revenue (2012-2017)

3.3.1.1 United States Immune system drugs Sales () and Market Share (2012-2017)

3.3.1.2 United States Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.1.3 United States Immune system drugs Price ()(2012-2017)

3.3.2 Canada Immune system drugs Sales and Revenue (2012-2017)

3.3.2.1 Canada Immune system drugs Sales () and Market Share (2012-2017)

3.3.2.2 Canada Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.2.3 Canada Immune system drugs Price ()(2012-2017)

3.4 Latin America Immune system drugs Sales and Revenue by Regions (2012-2017)

3.4.1 Brazil Immune system drugs Sales and Revenue (2012-2017)

3.4.1.1 Brazil Immune system drugs Sales () and Market Share (2012-2017)

3.4.1.2 Brazil Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.1.3 Brazil Immune system drugs Price ()(2012-2017)

3.4.2 Mexico Immune system drugs Sales and Revenue (2012-2017)

3.4.2.1 Mexico Immune system drugs Sales () and Market Share (2012-2017)

3.4.2.2 Mexico Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.2.3 Mexico Immune system drugs Price ()(2012-2017)

3.4.3 Others Immune system drugs Sales and Revenue (2012-2017)

3.4.3.1 Others Immune system drugs Sales () and Market Share (2012-2017)

3.4.3.2 Others Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.3.3 Others Immune system drugs Price ()(2012-2017)

3.5 Southeast Asia Immune system drugs Sales and Revenue by Regions (2012-2017)

3.5.1 Singapore Immune system drugs Sales and Revenue (2012-2017)

3.5.1.1 Singapore Immune system drugs Sales () and Market Share (2012-2017)

3.5.1.2 Singapore Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.1.3 Singapore Immune system drugs Price ()(2012-2017)

3.5.2 Malaysia Immune system drugs Sales and Revenue (2012-2017)

3.5.2.1 Malaysia Immune system drugs Sales () and Market Share (2012-2017)

3.5.2.2 Malaysia Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.2.3 Malaysia Immune system drugs Price ()(2012-2017)

3.5.3 Vietnam Immune system drugs Sales and Revenue (2012-2017)

3.5.3.1 Vietnam Immune system drugs Sales () and Market Share (2012-2017)

3.5.3.2 Vietnam Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.3.3 Vietnam Immune system drugs Price ()(2012-2017)

3.5.4 Myanmar Immune system drugs Sales and Revenue (2012-2017)

3.5.4.1 Myanmar Immune system drugs Sales () and Market Share (2012-2017)

3.5.4.2 Myanmar Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.4.3 Myanmar Immune system drugs Price ()(2012-2017)

3.5.5 Thailand Immune system drugs Sales and Revenue (2012-2017)

3.5.5.1 Thailand Immune system drugs Sales () and Market Share (2012-2017)

3.5.5.2 Thailand Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.5.3 Thailand Immune system drugs Price ()(2012-2017)

3.5.6 Indonesia Immune system drugs Sales and Revenue (2012-2017)

3.5.6.1 Indonesia Immune system drugs Sales () and Market Share (2012-2017)

3.5.6.2 Indonesia Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.6.3 Indonesia Immune system drugs Price ()(2012-2017)

3.5.7 Philippines Immune system drugs Sales and Revenue (2012-2017)

3.5.7.1 Philippines Immune system drugs Sales () and Market Share (2012-2017)

3.5.7.2 Philippines Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.7.3 Philippines Immune system drugs Price ()(2012-2017)

3.5.8 Others Immune system drugs Sales and Revenue (2012-2017)

3.5.8.1 Others Immune system drugs Sales () and Market Share (2012-2017)

3.5.8.2 Others Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.8.3 Others Immune system drugs Price ()(2012-2017)

3.6 Middle East & Africa Immune system drugs Sales and Revenue by Regions (2012-2017)

3.6.1 Saudi Arabia Immune system drugs Sales and Revenue (2012-2017)

3.6.1.1 Saudi Arabia Immune system drugs Sales () and Market Share (2012-2017)

3.6.1.2 Saudi Arabia Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.1.3 Saudi Arabia Immune system drugs Price ()(2012-2017)

3.6.2 Iran Immune system drugs Sales and Revenue (2012-2017)

3.6.2.1 Iran Immune system drugs Sales () and Market Share (2012-2017)

3.6.2.2 Iran Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.2.3 Iran Immune system drugs Price ()(2012-2017)

3.6.3 UAE Immune system drugs Sales and Revenue (2012-2017)

3.6.3.1 UAE Immune system drugs Sales () and Market Share (2012-2017)

3.6.3.2 UAE Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.3.3 UAE Immune system drugs Price ()(2012-2017)

3.6.4 Turkey Immune system drugs Sales and Revenue (2012-2017)

3.6.4.1 Turkey Immune system drugs Sales () and Market Share (2012-2017)

3.6.4.2 Turkey Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.4.3 Turkey Immune system drugs Price ()(2012-2017)

3.6.5 Israel Immune system drugs Sales and Revenue (2012-2017)

3.6.5.1 Israel Immune system drugs Sales () and Market Share (2012-2017)

3.6.5.2 Israel Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.5.3 Israel Immune system drugs Price ()(2012-2017)

3.6.6 Egypt Immune system drugs Sales and Revenue (2012-2017)

3.6.6.1 Egypt Immune system drugs Sales () and Market Share (2012-2017)

3.6.6.2 Egypt Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.6.3 Egypt Immune system drugs Price ()(2012-2017)

3.6.7 South Africa Immune system drugs Sales and Revenue (2012-2017)

3.6.7.1 South Africa Immune system drugs Sales () and Market Share (2012-2017)

3.6.7.2 South Africa Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.7.3 South Africa Immune system drugs Price ()(2012-2017)

3.6.8 Others Immune system drugs Sales and Revenue (2012-2017)

3.6.8.1 Others Immune system drugs Sales () and Market Share (2012-2017)

3.6.8.2 Others Immune system drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.8.3 Others Immune system drugs Price ()(2012-2017)



4 Global and Japan Immune system drugs Players/Manufacturers Profiles and Sales Data

4.1 Asahi Kasei Pharma Corporation

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Immune system drugs Product Category, Application and Specification

4.1.2.1 Product A

4.1.2.2 Product B

4.1.3 Asahi Kasei Pharma Corporation Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.1.4 Main Business/Business Overview

4.2 Aspen Japan K.K.

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Immune system drugs Product Category, Application and Specification

4.2.2.1 Product A

4.2.2.2 Product B

4.2.3 Aspen Japan K.K. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.2.4 Main Business/Business Overview

4.3 AYUMI Pharmaceutical Co., Ltd.

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Immune system drugs Product Category, Application and Specification

4.3.2.1 Product A

4.3.2.2 Product B

4.3.3 AYUMI Pharmaceutical Co., Ltd. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.3.4 Main Business/Business Overview

4.4 Mitsubishi Tanabe Pharma Corporation

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Immune system drugs Product Category, Application and Specification

4.4.2.1 Product A

4.4.2.2 Product B

4.4.3 Mitsubishi Tanabe Pharma Corporation Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.4.4 Main Business/Business Overview

4.5 Nichi-iko Pharmaceutical Co.,Ltd

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Immune system drugs Product Category, Application and Specification

4.5.2.1 Product A

4.5.2.2 Product B

4.5.3 Nichi-iko Pharmaceutical Co.,Ltd Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.5.4 Main Business/Business Overview

4.6 NIPPON KAYAKU

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Immune system drugs Product Category, Application and Specification

4.6.2.1 Product A

4.6.2.2 Product B

4.6.3 NIPPON KAYAKU Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.6.4 Main Business/Business Overview

4.7 NIPRO CORPORATION

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Immune system drugs Product Category, Application and Specification

4.7.2.1 Product A

4.7.2.2 Product B

4.7.3 NIPRO CORPORATION Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.7.4 Main Business/Business Overview

4.8 Novartis Pharma K.K.

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Immune system drugs Product Category, Application and Specification

4.8.2.1 Product A

4.8.2.2 Product B

4.8.3 Novartis Pharma K.K. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.8.4 Main Business/Business Overview

4.9 Pfizer Pharmaceuticals Inc.

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Immune system drugs Product Category, Application and Specification

4.9.2.1 Product A

4.9.2.2 Product B

4.9.3 Pfizer Pharmaceuticals Inc. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.9.4 Main Business/Business Overview

4.10 POLA PHARMA INC.

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Immune system drugs Product Category, Application and Specification

4.10.2.1 Product A

4.10.2.2 Product B

4.10.3 POLA PHARMA INC. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.10.4 Main Business/Business Overview

4.11 Sawai Pharmaceutical Co.,Ltd.

4.12 Teva Takeda Pharma Ltd.



5 Immune system drugs Manufacturing Cost Analysis

5.1 Immune system drugs Key Raw Materials Analysis

5.1.1 Key Raw Materials

5.1.2 Price Trend of Key Raw Materials

5.1.3 Key Suppliers of Raw Materials

5.1.4 Market Concentration Rate of Raw Materials

5.2 Proportion of Manufacturing Cost Structure

5.2.1 Raw Materials

5.2.2 Labor Cost

5.2.3 Manufacturing Expenses

5.3 Manufacturing Process Analysis of Immune system drugs



6 Industrial Chain, Sourcing Strategy and Downstream Buyers

6.1 Immune system drugs Industrial Chain Analysis

6.2 Upstream Raw Materials Sourcing

6.3 Raw Materials Sources of Immune system drugs Major Players/Manufacturers in 2016

6.4 Downstream Buyers



7 Marketing Strategy Analysis, Distributors/Traders

7.1 Marketing Channel

7.1.1 Direct Marketing

7.1.2 Indirect Marketing

7.1.3 Marketing Channel Development Trend

7.2 Market Positioning

7.2.1 Pricing Strategy

7.2.2 Brand Strategy

7.2.3 Target Client

7.3 Distributors/Traders List



8 Market Effect Factors Analysis

8.1 Technology Progress/Risk

8.1.1 Substitutes Threat

8.1.2 Technology Progress in Related Industry

8.2 Consumer Needs/Customer Preference Change

8.3 Economic/Political Environmental Change



9 Global and Japan Immune system drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global and Japan Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global and Japan Immune system drugs Sales () Forecast by Type (2017-2022)

9.2.1 by Immunosuppressive drugs

9.2.2 by Immunoregulants

9.3 Global and Japan Immune system drugs Sales () Forecast by Application (2017-2022)

9.4 Global and Japan Immune system drugs Sales () Forecast by Regions (2017-2022)



10 Research Findings and Conclusion



11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Disclaimer

11.4 Author List





List of Table

List of Tables and Figures



Figure Product Picture of Immune system drugs

Table Japan Immune system drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Japan Sales Market Share (%) of Immune system drugs by Applications in 2016

Table Global Immune system drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Global Sales Market Share (%) of Immune system drugs by Applications in 2016

Figure Internal Medicine Examples

Table Key Downstream Customer in Internal Medicine

Figure Department of surgery Examples

Table Key Downstream Customer in Department of surgery

Figure Infections Department Examples

Table Key Downstream Customer in Infections Department

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Azathioprine Product Picture

Figure Tripterygium Glycosides Product Picture

Figure Cyclosporine Product Picture

Figure Sandimmune Product Picture

Figure Ciclosporin Product Picture

Figure Inosine pranobex Product Picture

Figure Melotonin Product Picture

Figure Killer helper factor,KHF Product Picture

Figure Thymopentin Product Picture

Figure Interleukin Product Picture

Table Asahi Kasei Pharma Corporation Basic Information List

Table Asahi Kasei Pharma Corporation Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Asahi Kasei Pharma Corporation Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Asahi Kasei Pharma Corporation Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Asahi Kasei Pharma Corporation Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Aspen Japan K.K. Basic Information List

Table Aspen Japan K.K. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Aspen Japan K.K. Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Aspen Japan K.K. Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Aspen Japan K.K. Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table AYUMI Pharmaceutical Co., Ltd. Basic Information List

Table AYUMI Pharmaceutical Co., Ltd. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AYUMI Pharmaceutical Co., Ltd. Immune system drugs Sales Growth Rate (%)(2012-2017)

Table AYUMI Pharmaceutical Co., Ltd. Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure AYUMI Pharmaceutical Co., Ltd. Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Mitsubishi Tanabe Pharma Corporation Basic Information List

Table Mitsubishi Tanabe Pharma Corporation Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Mitsubishi Tanabe Pharma Corporation Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Mitsubishi Tanabe Pharma Corporation Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Mitsubishi Tanabe Pharma Corporation Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Nichi-iko Pharmaceutical Co.,Ltd Basic Information List

Table Nichi-iko Pharmaceutical Co.,Ltd Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Nichi-iko Pharmaceutical Co.,Ltd Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Nichi-iko Pharmaceutical Co.,Ltd Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Nichi-iko Pharmaceutical Co.,Ltd Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table NIPPON KAYAKU Basic Information List

Table NIPPON KAYAKU Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table NIPPON KAYAKU Immune system drugs Sales Growth Rate (%)(2012-2017)

Table NIPPON KAYAKU Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure NIPPON KAYAKU Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table NIPRO CORPORATION Basic Information List

Table NIPRO CORPORATION Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table NIPRO CORPORATION Immune system drugs Sales Growth Rate (%)(2012-2017)

Table NIPRO CORPORATION Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure NIPRO CORPORATION Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Novartis Pharma K.K. Basic Information List

Table Novartis Pharma K.K. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Novartis Pharma K.K. Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Novartis Pharma K.K. Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Novartis Pharma K.K. Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Pfizer Pharmaceuticals Inc. Basic Information List

Table Pfizer Pharmaceuticals Inc. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Pfizer Pharmaceuticals Inc. Immune system drugs Sales Growth Rate (%)(2012-2017)

Table Pfizer Pharmaceuticals Inc. Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure Pfizer Pharmaceuticals Inc. Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table POLA PHARMA INC. Basic Information List

Table POLA PHARMA INC. Immune system drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table POLA PHARMA INC. Immune system drugs Sales Growth Rate (%)(2012-2017)

Table POLA PHARMA INC. Immune system drugs Sales Market Share (%) in Japan (2012-2017)

Figure POLA PHARMA INC. Immune system drugs Revenue Market Share (%) in Japan (2012-2017)

Table Sawai Pharmaceutical Co.,Ltd. Basic Information List

Table Teva Takeda Pharma Ltd. Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Immune system drugs

Figure Manufacturing Process Analysis of Immune system drugs

Figure Immune system drugs Industrial Chain Analysis

Table Raw Materials Sources of Immune system drugs Major Players/Manufacturers in 2016

Table Major Buyers of Immune system drugs

Table Distributors/Traders List

Figure Japan Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Japan Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Immune system drugs Price () Trend Forecast (2017-2022)

Figure Global Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Immune system drugs Price () Trend Forecast (2017-2022)

Table Japan Immune system drugs Sales () Forecast by Type (2017-2022)

Table Global Immune system drugs Sales () Forecast by Type (2017-2022)

Figure Japan Immune system drugs Sales () Forecast by Type (2017-2022)

Figure Global Immune system drugs Sales () Forecast by Type (2017-2022)

Figure Japan Immune system drugs Sales Volume Market Share Forecast by Type in 2017

Figure Global Immune system drugs Sales Volume Market Share Forecast by Type in 2017

Table Japan Immune system drugs Sales () Forecast by Application (2017-2022)

Figure Japan Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Japan Immune system drugs Sales Volume Market Share Forecast by Application in 2017

Table Global Immune system drugs Sales () Forecast by Application (2017-2022)

Figure Global Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Immune system drugs Sales Volume Market Share Forecast by Application in 2017

Table Japan Immune system drugs Sales () Forecast by Regions (2017-2022)

Table Japan Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Japan Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Global Immune system drugs Sales () Forecast by Regions (2017-2022)

Table Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources



Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *